Toxic Legacy: The Threat of PFAS Contamination from UK Military Bases

Per- and polyfluoroalkyl substances (PFAS), often referred to as “forever chemicals,” have emerged as one of the most persistent and hazardous pollutants in modern environmental health. Their resistance to degradation allows them to linger in soil, water, and the human body for decades, raising global alarm over their potential health impacts. In the United Kingdom, growing attention is being directed toward military bases such as RAF Marham, RM Chivenor, and AAC Middle Wallop, where historical PFAS use may be contaminating nearby drinking water sources. As investigations begin, communities and environmental experts alike are demanding accountability and urgent action.

What Are PFAS and Why They Matter

PFAS, or per- and polyfluoroalkyl substances, are a group of over 4,000 synthetic chemicals used since the 1940s in a wide array of consumer products, including non-stick cookware, water-resistant fabrics, and food packaging. Their chemical structure, characterized by strong carbon-fluorine bonds, makes them incredibly resistant to heat, oil, water, and degradation—earning them the nickname "forever chemicals."

While their industrial utility is undeniable, the environmental and health consequences are increasingly concerning. PFAS are known to accumulate in the human body over time, with exposure linked to a range of adverse health outcomes, including certain cancers, immune system suppression, hormonal disruptions, liver damage, and reproductive issues. Once released into the environment, PFAS persist in soil and water, infiltrating food chains and drinking water supplies.

In the UK, routine environmental monitoring has lagged behind other nations, leaving many regions potentially unaware of existing contamination. This is especially troubling in light of new studies suggesting widespread PFAS presence in surface and groundwater. The risk is particularly acute around areas of historic industrial or military activity—such as air bases—where PFAS-laden firefighting foams were heavily used. Understanding what PFAS are and why they matter is a critical first step in addressing their growing threat.

The Military Connection

Military installations around the world have long used firefighting foams containing PFAS, particularly aqueous film-forming foams (AFFF), due to their effectiveness in suppressing high-intensity fuel fires. In the UK, this practice was especially prevalent during training exercises and emergency responses at air force and army bases. Over time, repeated use of these foams has led to significant PFAS buildup in the surrounding soil and water.

Recent investigations have focused on three UK military sites—RAF Marham in Norfolk, RM Chivenor in Devon, and AAC Middle Wallop in Hampshire. These bases are situated near sensitive environments and, in some cases, within proximity to drinking water catchment areas. Concerns are mounting that PFAS from these sites may be leaching into local water supplies, posing a long-term threat to both environmental and public health.

The Ministry of Defence (MoD) has acknowledged the potential for contamination and initiated assessments at the bases. However, critics argue that these efforts are reactive rather than preventative, pointing to the lack of transparency and historical oversight. The situation underscores the pressing need for comprehensive PFAS monitoring, particularly in areas tied to defense operations, where the use of hazardous chemicals was often extensive and underregulated.

Current Investigations and Public Concerns

The UK Ministry of Defence has launched investigations into the potential contamination at RAF Marham, RM Chivenor, and AAC Middle Wallop, following pressure from environmental watchdogs and local residents. Initial assessments are underway to determine the extent of PFAS pollution, particularly in nearby groundwater and soil. However, the MoD has yet to publish detailed findings or a clear action plan for remediation, drawing criticism for its perceived lack of urgency.

Environmental groups such as CHEM Trust and Friends of the Earth have voiced serious concerns about the health implications for communities living near these bases. They warn that prolonged exposure to PFAS-contaminated water can have irreversible effects, especially on vulnerable populations such as children and pregnant women. Local councils have echoed these concerns, calling for more rigorous testing and public disclosure of risks.

Some residents have expressed frustration over the MoD’s communication, citing fears about the safety of their drinking water and the long-term environmental damage. Calls for independent testing and an overhaul of the UK’s PFAS regulation framework are growing louder. The ongoing investigations have not only spotlighted legacy pollution from military activities but also raised questions about institutional accountability in managing environmental health risks.

Comparative Global Response

Globally, countries like the United States and Australia have taken more aggressive stances on PFAS contamination, especially where military sites are involved. In the U.S., the Department of Defense has identified hundreds of military facilities with confirmed or suspected PFAS releases, prompting large-scale testing and remediation efforts. Some states have implemented strict drinking water standards, and legal actions against PFAS manufacturers have resulted in multimillion-dollar settlements.

In contrast, the UK’s approach has been slower and less coordinated. While the Environment Agency has begun mapping high-risk PFAS sites, many water utilities still lack the infrastructure to filter out these chemicals effectively. Moreover, the absence of legally binding national standards for PFAS in drinking water creates regulatory ambiguity.

This disparity highlights the need for the UK to not only accelerate investigations and clean-up efforts but also to adopt best practices from international counterparts who are confronting PFAS challenges with greater transparency, urgency, and technical capacity.

What’s Next: Policy and Accountability

The growing evidence of PFAS contamination near UK military bases underscores an urgent need for stronger regulatory oversight and clearer accountability mechanisms. Environmental advocates are calling for legally enforceable PFAS limits in drinking water and a national strategy for testing and remediation. Additionally, experts stress the importance of upgrading water treatment infrastructure to handle these persistent pollutants.

There is also a growing push to shift the financial burden of cleanup from taxpayers to the chemical industry. The principle of “polluter pays” is gaining traction, with campaigners urging the UK government to hold PFAS manufacturers and major users accountable for historical and ongoing contamination.

Equally important is the demand for transparency. Communities have a right to know the risks they face and the steps being taken to address them. Without timely and open communication, trust in public institutions erodes. Meaningful policy reform and corporate accountability are essential to mitigating PFAS's long-term impact.

Cold Weather Working in the UK: Keeping Staff Safe and Warm

As winter's chill sets in, bringing with it frosty mornings and icy breezes, it's crucial for employers across the UK to turn their attention to the safety and well-being of their workforce. Cold weather isn't just about discomfort; it brings real challenges to the workplace, affecting both health and productivity. In this light, understanding the legal and safety guidelines becomes not just a necessity but a responsibility. This blog post delves into the UK's legal framework and the Health and Safety Executive (HSE) standards, guiding employers on how to navigate the complexities of cold weather working. Whether you're managing an outdoor construction team or an indoor office environment, staying informed and prepared is key to ensuring a safe and comfortable workspace for everyone.

Understanding the HSE Guidelines and What They Mean for Employers

The arrival of cold weather signals more than just a change in wardrobe; for employers, it's a call to action to safeguard their employees' health and safety. The Health and Safety Executive (HSE) of Great Britain plays a pivotal role in this, emphasizing the need for workplaces to adapt to the dipping temperatures. According to the HSE, the onset of cold weather, often marked by warnings from the Met Office, should prompt a reevaluation of working conditions, particularly in jobs that become increasingly challenging in such climates.

Central to this is the adherence to the Workplace (Health, Safety and Welfare) Regulations 1992. These regulations don't dictate exact temperature figures but require employers to maintain what's deemed a "reasonable" temperature in the workplace. While "reasonable" might seem subjective, the HSE provides a guideline suggesting that the minimum indoor temperature should generally be at least 16 degrees Celsius (61 degrees Fahrenheit), or 13 degrees Celsius (55 degrees Fahrenheit) for more physically demanding work.

However, it's important to note that these temperatures are not strict legal limits but rather recommendations that demand a practical approach from employers. What constitutes a reasonable temperature can vary widely depending on the nature of the work and the workplace. For instance, outdoor workers or those in cold storage environments might find themselves outside these temperature ranges.

This means that employers must go beyond just monitoring thermostats. They are tasked with conducting risk assessments to identify if extreme temperatures could pose a health and safety risk. This includes considering potential accident risks due to cold conditions and ensuring basic staff welfare facilities are in place. If these cannot be provided, it may be unsafe for employees to work.

The crux of these guidelines is not in strict adherence to a numerical value but in a broader sense of responsibility. Employers are expected to tailor their approach to the specific circumstances of their workplace, always with the safety and comfort of their employees in mind.

The Real Impact of Cold on Workers: Health, Safety, and Performance

When winter's icy grip tightens, it's not just the outdoor landscape that changes; the cold can significantly impact the health, safety, and performance of workers. The Health and Safety Executive (HSE) warns that cold environments can pose immediate and long-term health risks. For outdoor workers, the challenges are evident: they face the direct brunt of the elements, which can lead to conditions like cold stress, characterized by symptoms such as coughing and body aches.

But it's not just physical health that's at stake. John Rowe, Head of Operational Strategy at the HSE, highlights a crucial yet often overlooked aspect: cold conditions can impair decision-making abilities. Employees working in uncomfortably cold environments are less likely to perform optimally and more prone to unsafe behaviors, as their ability to make good decisions deteriorates.

This dual impact – on both physical health and cognitive function – underscores the importance of a proactive approach to managing workplace temperatures. Whether it's an outdoor construction site or a drafty office space, ensuring that workers are not just physically protected but also mentally sharp is vital. As the temperatures drop, the focus shouldn't just be on thermometers but on the overall well-being of those braving the cold to keep businesses running.

Practical Tips for Employers: Keeping Your Team Warm and Safe

In the face of cold weather, practical steps taken by employers can make a significant difference in ensuring a warm and safe working environment. These measures are not just about compliance with regulations but about demonstrating care and concern for the team's well-being.

1. Appropriate Personal Protective Equipment (PPE): For outdoor work, providing suitable PPE is crucial. This includes warm clothing, insulated hats, and gloves, which are essential for worker safety in cold outdoor temperatures. The Personal Protective Equipment Regulations 1992 underscore the importance of providing such equipment free of charge when there's a risk to health or safety.

2. Creating Warm Break Areas: Employers should consider providing mobile facilities for warming up, along with access to hot drinks like soup or tea. This not only helps in maintaining body temperature but also offers a mental break from the cold.

3. Frequent Rest Breaks: Introducing more frequent rest breaks can be an effective way to manage the impact of cold weather on workers. These breaks allow employees to warm up and reduce the risk of cold stress.

4. Maintaining Indoor Temperatures: For indoor work environments, it's important to keep the building as warm as possible, ideally around 16°C (61°F) for less active job roles. Ensuring fresh running water and allowing extra breaks for warm drinks can also help.

5. Regular Check-ins and Weather Monitoring: Keeping an eye on the weather forecast for worsening conditions and checking in on staff regularly to ensure their well-being should be part of the routine.

By implementing these measures, employers can provide a more comfortable and safer working environment, thereby enhancing productivity and morale even during the coldest months.

Success Stories: How UK Businesses Are Adapting to Cold Weather Working

Amid the challenges of cold weather, there are numerous UK businesses that stand as beacons of best practices, showcasing innovative and caring approaches to keep their teams safe and productive. These success stories not only highlight compliance with health and safety regulations but also demonstrate a commitment to employee well-being that goes beyond mere obligations.

One such example is a construction company in Northern England that has set a high standard for outdoor working in the cold. Recognizing the risks posed by freezing temperatures, they have implemented a comprehensive cold-weather strategy. This includes providing high-quality thermal PPE, setting up heated break tents on-site, and scheduling work to minimize exposure during the coldest parts of the day. Their proactive approach has resulted in a notable decrease in cold-related absences and an increase in worker morale.

Another case involves a large office complex in Scotland, where management took steps to combat the challenges posed by a particularly harsh winter. They enhanced their building's insulation, provided additional space heaters in colder areas, and introduced flexible working hours to help staff avoid the chill of early mornings. These measures not only kept the workforce warm but also conveyed a strong message of care and concern for employee comfort.

These stories underscore that adapting to cold weather working is as much about innovation and empathy as it is about adhering to guidelines. They serve as inspiring examples for other businesses looking to navigate the winter months effectively while keeping their teams safe and motivated.

Wrapping Up: Staying Safe and Productive in the Cold

As we've seen, navigating the cold weather at work is about more than just enduring lower temperatures. It's about creating an environment where safety, health, and productivity go hand in hand. Employers who recognize this not only comply with regulations but also foster a workplace culture of care and respect. Whether it's through providing the right equipment, maintaining comfortable temperatures, or simply being attentive to employee needs, the efforts made to combat the cold can have a profound impact. As winter marches on, let's remember that a warm approach to employee well-being is key to thriving through the season.

New Molnupiravir Covid Antiviral Treatment

Molnupiravir is a new antiviral treatment currently in Phase III of its clinical trials in the United Kingdom.

It was developed by the private company Mavenir Therapeutics and is ideal for people infected with HCV who have already completed therapy with an appropriate antiviral agent.

Molnupiravir Covid Treatment Advances In The Fight Against The Pandemic

Molnupiravir covid treatment is an antiviral drug that is effective in its treatment during the pandemic.

Early drug trials have shown a rapid onset action against the virus, and patients tolerate it well.

The United States Food and Drug Administration (FDA) has also approved its use for treating influenza A H1N1 virus infection in adults aged 18 years or older, including pregnant women.

Molnupiravir may also be used to treat other strains of pandemic flu viruses, including seasonal flu; however, there is currently no data from clinical trials that support this use.

Side effects from this treatment are typically mild and include headache, body aches, sore throat, cough, and fever which usually resolve within seven days after beginning treatment. The effects will become more evident as its use becomes more prevalent. However, rare cases have been reported where patients develop a severe respiratory illness such as pneumonia or death.

How Molnupiravir Covid Works To Combat The Virus

Molnupiravir is an antiviral medication given to patients twice a day for five days while infected with the omicron variant of Covid. 

The pill is taken by mouth daily and selected for patients with a higher risk of death or severe hospitalization from Covid, many with underlying ailments associated with age or other health conditions.

While early trials appeared to aid the recovery of treated patients significantly, the data still does not correlate with any significant decreases in covid associated death rates or hospital admissions. 

Side Effects Of Covid Drugs And How To Minimize The

Covid drugs can cause various side effects, some of which have been serious and others with unknown long-term consequences.

Be sure to speak with your doctor or pharmacist about any potential side effects before starting this treatment, as there are many types of recovery aids to help those outside of high-risk categories.

Side effects of the new medication can include nausea, vomiting, diarrhea, and stomach pain which should all be communicated to your primary physician. 

Some people taking the drug have also experienced changes in their mood or behavior, but any increase in anxiety or depressive symptoms should be addressed immediately by a doctor.

Make sure to notify your doctor if you are using other medications concurrently that could interact with the Covid drug(s) you are prescribed.

Consult a healthcare professional if there is unexplained weight loss or increased appetite when using this coronavirus therapy. The drug has also been shown to react differently with diabetic patients with an increased risk for hypoglycemia and low blood sugar, which may impair the body’s renal function. 

The Current Status Of Covid Treatment And Future Prospects

The current status of this new Covid treatment is highly effective against the virus, with a 95% successful recovery rate in the usual two-week recovery period.

Critics of the therapy suggest many of the unwanted side effects make this treatment undesirable for patients outside high-risk categories. 

There has been significant research in the past few years to find new and better ways to treat Covid, which may improve the success rate even more in the future, and this is just one of those treatments.

Prospects for Covid treatment are very positive as new technologies are being developed all the time.

Patient Outcomes Following Administration Of Covid Therapies

Covid antiviral treatments have resulted in a marked decrease in patients developing illness complications and death.

The use of Covid therapies has also led to a significant reduction in the spread of the virus, meaning that fewer people are affected by it at any time. The resulting decrease in the transmission is due to the shortening of the recovery period and lessening the duration of transmissible symptoms like coughing.

While some risks are still associated with using Covid therapies, these have been significantly reduced over time as researchers continue to develop new ways to prevent severe complications from the pandemic virus.

Patients who receive Covid therapy often experience faster recoveries than those patients who do not receive treatment.

Overall, patient outcomes following the administration of Covid therapies are very positive and demonstrate clear benefits for both infected individuals and society as a whole.

Lessons Learned From Molnupiravir Covid Trials

1. Antiviral treatments are not a cure-all and should always be combined with other therapies to take advantage of their potential best.

2. New, more effective antiviral treatments are being developed continuously, and patients should remain informed about available options.

3. Many different side effects can occur when taking antiviral medications, but most tend to be mild and short-term.

4. Patients need to remain as active as possible while on an antiviral medication to reduce the risk of complications from the virus or the treatment itself (i.e., build-up of drug resistance).

Wind Harmony: Seeking Your Views on the Health and Safety Issues of the Wind Energy Sector in the EU

The Wind Harmony project has just launched an online survey  to seek your views on the key health and safety issues currently facing the European wind industry, and potential solutions to those issues. The project seeks to understand where harmonisation or alignment at European level could reduce complexity, risk and cost, improve industry performance and lay the foundations for global wind industry standards.

The survey is open to everyone – including manufacturers, developers, operators, contractors (of all sizes), regulators, policy makers, national wind energy associations, researchers and technicians. Responses are anonymised and will feed directly into the next project workshop and inform the project’s final recommendations. The survey should take no more than 10 minutes to complete. The survey is also available in French, German and Spanish, and open until 2nd March 2020.

Access the survey 

You can also register for the 3rd workshop of the ‘Wind Harmony’ study that will take place on Friday 13th March (Paris). This workshop will validate the topics for potential harmonisation of health and safety and identify possible interventions for each of these topics based on expected improvements, cost reduction and overall efficiency. Check the detailed agenda and register here before 3rd March 2020.

More information on the project can be found at www.windharmony.eu .